Atrys Health SL Total Liabilities
Atrys Health SL total liabilities. Based on the latest financial reports, Atrys Health SL (ATRY) has total liabilities worth €168.11 Million EUR (≈ $196.53 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Atrys Health SL (ATRY) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Atrys Health SL (2012–2025)
Total liabilities of Atrys Health SL from 2012 to 2025. This chart illustrates how Atrys Health SL's total liabilities have evolved over time, based on quarterly financial data.
Atrys Health SL Competitors by Total Liabilities
The table below lists competitors of Atrys Health SL ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mastersystem Infotama Tbk.
JK:MSTI
|
Indonesia | Rp1.01 Trillion |
|
Grupo Hotelero Santa Fe SAB
MX:HOTEL
|
Mexico | MX$4.28 Billion |
|
Kalekim Kimyevi Maddeler Sanayi & Ticaret AS
IS:KLKIM
|
Turkey | TL2.89 Billion |
|
Lightron Inc.
KQ:069540
|
Korea | ₩28.14 Billion |
|
Garanti Faktoring AS
IS:GARFA
|
Turkey | TL21.69 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩17.10 Billion |
|
Politeknik Metal Sanayi ve
IS:POLTK
|
Turkey | TL30.41 Million |
|
Sekerbank TAS
IS:SKBNK
|
Turkey | TL265.57 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Atrys Health SL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Atrys Health SL (ATRY) total assets.
Liquidity & Leverage Metrics
Atrys Health SL Total Liabilities Ratios Explained
Atrys Health SL total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Atrys Health SL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Atrys Health SL (2012–2025)
The table below shows the annual total liabilities of Atrys Health SL from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €342.08 Million ≈ $399.93 Million |
+3.36% |
| 2024-12-31 | €330.95 Million ≈ $386.92 Million |
-2.41% |
| 2023-12-31 | €339.12 Million ≈ $396.47 Million |
-7.77% |
| 2022-12-31 | €367.71 Million ≈ $429.89 Million |
+26.08% |
| 2021-12-31 | €291.65 Million ≈ $340.97 Million |
+190.35% |
| 2020-12-31 | €100.45 Million ≈ $117.43 Million |
+108.88% |
| 2019-12-31 | €48.09 Million ≈ $56.22 Million |
+76.47% |
| 2018-12-31 | €27.25 Million ≈ $31.86 Million |
+61.25% |
| 2017-12-31 | €16.90 Million ≈ $19.76 Million |
+3.64% |
| 2016-12-31 | €16.31 Million ≈ $19.06 Million |
+13.27% |
| 2015-12-31 | €14.40 Million ≈ $16.83 Million |
+14.17% |
| 2014-12-31 | €12.61 Million ≈ $14.74 Million |
+2.90% |
| 2013-12-31 | €12.25 Million ≈ $14.33 Million |
+0.14% |
| 2012-12-31 | €12.24 Million ≈ $14.31 Million |
-- |
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fi… Read more